BioPharma Drug Discovery
Axcelead Drug Discovery Partners Joins Forces with Astellas Pharma to Advance Targeted Protein Degrader Research
Axcelead Drug Discovery Partners, Inc. announced today that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Ch...
December 26, 2024 | News
Keymed Biosciences Secures NMPA Approval for Stapokibart to Treat Chronic Rhinosinusitis with Nasal Polyposis
Keymed Biosciences Inc. announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New D...
December 24, 2024 | News
Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
Antibody-Drug Conjugates (ADCs) represent a paradigm shift in oncology, offering targeted cancer treatment that minimizes collateral damage to healthy cell...
December 23, 2024 | News
Vertex Announces FDA Approval of ALYFTREK™: A Once-Daily CFTR Modulator for Cystic Fibrosis Patients Aged 6 and Older
ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not re...
December 23, 2024 | News
CStone Pharmaceuticals Submits Clinical Trial Application in Australia for CS2009, a Tri-Specific Antibody Targeting Solid Tumors
CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therap...
December 23, 2024 | News
SCG Cell Therapy Partners with A*STAR BTI and NATi to Accelerate RNA-Based Therapeutics Development and Commercialization
SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Ini...
December 23, 2024 | News
Sanofi Acquires Greater China Rights for Aficamten from CORXEL, Expanding HCM Treatment Reach
Cytokinetics, Incorporated announced that Sanofi will acquire exclusive rights to develop and commercialize aficamten from Corxel Pharmaceuticals (CORXEL...
December 20, 2024 | News
Hong Kong DoH Approves AGAMREE® for Duchenne Muscular Dystrophy Treatment
Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older...
December 20, 2024 | News
Merck Accelerates Next-Generation Drug Discovery with Acquisition of HUB Organoids
HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fas...
December 19, 2024 | News
Everest Medicines’ VELSIPITY® Prescribed in Mainland China, Pioneering New Ulcerative Colitis Treatment under Hong Kong-Macau Connect
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
December 18, 2024 | News
25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
Biopharma in 2025: AI Transforming Drug Discovery and Precision Medicine The biopharma landscape in 2025 is poised for an unprecedented transformation, dr...
December 13, 2024 | Analysis
CureGene Secures NMPA Approval for Clinical Trial of Novel Antiplatelet Drug CG-0255 in China
CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular...
December 13, 2024 | News
Porton Pharma Solutions and Aojin Life Sciences Forge Strategic Partnership to Advance XDC Conjugate Drug Development
Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. ("Aojin Life Sciences"). Porton will...
December 13, 2024 | News
Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity&nb...
December 06, 2024 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
